系统综述作者识别随机对照试验中结局数据缺失参与者的指南
该指南旨在帮助系统综述作者识别随机对照试验报告中结局数据缺失的参与者。指南基于对缺失数据相关研究的回顾及专家迭代反馈制定,包括关键术语定义、19类可能缺失数据的参与者类别及判断缺失性的流程图。采用该指南可促进系统综述中缺失数据管理的透明性和一致性。
要点
- 指南提供19类可能缺失结局数据的参与者类别及判断流程图。
- 系统综述作者需在主要分析中选择「确定缺失」或「总可能缺失」来识别缺失。
- 建议进行敏感性分析以探索不同缺失分类方法的一致性。
核心结论
- 采用该指南有助于促进系统综述中缺失数据管理的透明性和一致性。
研究设计与样本
- 指南制定基于对缺失数据相关研究的回顾,以及通过健康研究方法学专家和系统综述作者参与的会议进行迭代反馈和完善。
主要发现
- 指南包括关键术语定义、19类随机对照试验报告中描述的可能有缺失数据的参与者类别,以及判断每个类别结局数据缺失性的流程图。
- 缺失性的判断依赖于试验作者如何报告这些类别并在分析中处理它们。
关键数值与推荐
- 系统综述作者在主要分析中应选择如何识别结局数据缺失的参与者,即使用「确定缺失数据」或「总可能缺失数据」。
- 然后选择一种在荟萃分析中处理缺失数据的方法。
- 应进行敏感性分析以探索与竞争性缺失分类选项的一致性。
临床怎么用
- 系统综述作者可依据该指南的流程图和19类参与者类别,系统识别随机对照试验报告中的缺失结局数据。
- 在主要分析中明确选择「确定缺失」或「总可能缺失」策略,并据此选择荟萃分析处理方法。
- 通过敏感性分析评估不同缺失分类选项对结果一致性的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: In order for authors of systematic reviews to address missing data in randomized controlled trials (RCTs), they need to first identify the number of trial participants with missing data. The objective of this study was to provide guidance for authors of systematic reviews on how to identify participants with missing outcome data in reports of RCTs. METHODS: Guidance statements were informed by a review of studies addressing the topic of missing data and an iterative process of feedback and refinement, through meetings involving experts in health research methodology and authors of systematic reviews. RESULTS: The proposed guidance includes (1) definitions of key terms, (2) 19 categories of participants described in RCT reports and who might have missing data, and (3) a flowchart on how to judge the outcome data missingness for each category. The judgment of missingness relies on how trial authors report on the categories and handle them in their analyses. Practically, for their primary analysis, systematic review authors should choose how to identify participants with missing outcome data (i.e., use either "definitely missing data" or "total possible missing data"), then select a method for handling missing data in meta-analysis. Sensitivity analyses should be undertaken to explore consistency with competing options for classifying patients as having missing data. CONCLUSION: Adopting the proposed guidance will help promote transparency and consistency regarding how missing data are managed in systematic reviews.
引用
- Kahale LA, Guyatt GH, Agoritsas T, et al. A guidance was developed to identify participants with missing outcome data in randomized controlled trials. J Clin Epidemiol. 2019. PMID: 31299357. doi:10.1016/j.jclinepi.2019.07.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。